Organism name | Bruguiera sexangula var.rhynchopetala |
---|---|
Genus | Bruguiera |
Family | Rhizophoraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Bruguiera |
---|---|
Linked NCBI taxonomy ID | 39983 |
Linked level | genus |
Family in NCBI taxonomy | Rhizophoraceae |
---|---|
ID | 40029 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005737
![]() |
Myricetin 3-rutinoside
/ Myricetin-3-O-rutinoside |
No. 1 | No. 15 |
![]() |
||||
C00005169
![]() |
Nicotiflorin
/ Nicotifloroside / Kaempferol 3-O-rutinoside / Kaempferol 3-O-(alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranoside / (-)-Kaempferol 3-O-(alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranoside |
CHEMBL431610
CHEMBL79790 CHEMBL255020 CHEMBL501550 CHEMBL498879 CHEMBL1419228 CHEMBL1875691 |
22 / 10 / 12 | No. 1 | No. 15 |
![]() |
||
C00005413
![]() |
Rutin
/ Birutan / 3-Rutinosylquercetin / Quercetin 3-O-rutinoside / (+)-Quercetin 3-O-rutinoside / Quercetin 3-O-beta-rutinoside / (+)-Quercetin 3-O-beta-rutinoside / 3,3',4',5,7-Pentahydroxyflavone 3-rutinoside / Quercetin 3-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside |
CHEMBL32579
CHEMBL310754 CHEMBL182108 CHEMBL226335 CHEMBL502782 CHEMBL1436093 CHEMBL1532989 |
D012431
|
25 / 18 / 16 | 29 / 8 | No. 1 | No. 15 |
![]() |
C00004444
![]() |
Tricin 7-glucoside
/ Tricin 7-O-glucoside / Tricin 7-O-beta-D-glucopyranoside |
No. 2 | No. 15 |
![]() |
||||
C00031169
![]() |
Rhyncoside D
/ (-)-Rhyncoside D |
No. 128 | No. 72 |
![]() |
||||
C00031168
![]() |
Rhyncoside C
/ (-)-Rhyncoside C |
No. 128 | No. 72 |
![]() |
||||
C00031167
![]() |
Rhyncoside B
/ (-)-Rhyncoside B |
No. 128 | No. 72 |
![]() |
||||
C00031166
![]() |
Rhyncoside A
|
No. 128 | No. 72 |
![]() |
||||
C00030699
![]() |
Lyoniside
/ (+)-Lyoniside |
CHEMBL466738
CHEMBL583884 |
No. 174 | No. 22 |
![]() |
|||
C00030465
![]() |
Hedyotisol C
|
CHEMBL388779
CHEMBL1761832 |
No. 907 |
![]() |
||||
C00030464
![]() |
Hedyotisol B
|
CHEMBL388779
CHEMBL1761832 |
No. 907 |
![]() |
||||
C00030463
![]() |
Hedyotisol A
|
CHEMBL388779
CHEMBL1761832 |
No. 907 |
![]() |
||||
C00031170
![]() |
Rhyncoside E
|
No. 907 |
![]() |
|||||
C00031171
![]() |
Rhyncoside F
|
No. 907 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P06746 | DNA polymerase beta | Enzyme | C00005169 C00005413 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00005169 C00005413 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00005169 C00005413 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00005169 C00005413 | 1 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00005169 C00005413 | 1 / 1 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00005169 C00005413 | 1 / 1 |
P14679 | Tyrosinase | Oxidoreductase | C00005413 | 4 / 2 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00005413 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00005413 | 0 / 0 |
P07237 | Protein disulfide-isomerase | Enzyme | C00005169 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00005413 | 0 / 3 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00005413 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00005169 | 2 / 3 |
P39748 | Flap endonuclease 1 | Enzyme | C00005169 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00005169 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00005413 | 0 / 0 |
P27487 | Dipeptidyl peptidase 4 | S9B | C00005413 | 0 / 1 |
Q9Y253 | DNA polymerase eta | Enzyme | C00005169 | 1 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00005169 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00005413 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00005169 | 0 / 0 |
P06276 | Cholinesterase | Hydrolase | C00005413 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00005413 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00005413 | 3 / 3 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00005413 | 2 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00005413 | 1 / 1 |
P22303 | Acetylcholinesterase | Hydrolase | C00005413 | 1 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00005413 | 0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00005169 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00005169 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00005169 | 1 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00005413 | 4 / 3 |
P48147 | Prolyl endopeptidase | S9A | C00005413 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00005169 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00005413 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00005169 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00005413 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00005169 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00005169 | 1 / 4 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00005169 | 0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00005169 | 2 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00005413
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00005413
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00005413
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00005413
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00005413
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00005413
|
847 | CAT | catalase (EC:1.11.1.6) |
C00005413
|
873 | CBR1, CBR, SDR21C1, hCBR1 | carbonyl reductase 1 (EC:1.1.1.189 1.1.1.197 1.1.1.184) |
C00005413
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00005413
|
3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00005413
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00005413
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00005413
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00005413
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00005413
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00005413
|
3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00005413
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00005413
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00005413
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00005413
|
3667 | IRS1, HIRS-1 | insulin receptor substrate 1 |
C00005413
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00005413
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00005413
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00005413
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00005413
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00005413
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00005413
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00005413
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00005413
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00005413
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#114500 | Colorectal cancer; crc |
Q14191
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#232300 | Glycogen storage disease ii |
P10253
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#277700 | Werner syndrome; wrn |
Q14191
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00032 | Thyroid cancer |
P27487
(marker)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00025 | Penile cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00296 | Defects in RecQ helicases |
Q14191
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D001424 | Bacterial Infections |
C00005413
|
D003092 | Colitis |
C00005413
|
D004409 | Dyskinesia, Drug-Induced |
C00005413
|
D015212 | Inflammatory Bowel Diseases |
C00005413
|
D007674 | Kidney Diseases |
C00005413
|
D028361 | Mitochondrial Diseases |
C00005413
|
D010243 | Paralysis |
C00005413
|
D013276 | Stomach Ulcer |
C00005413
|